The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abeona Therapeutics Inc. | COM | 00289Y107 | 7,483 | 2,288,235 | SH | SOLE | 2,288,235 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 1,747,759 | 40,854,586 | SH | SOLE | 40,854,586 | 0 | 0 | ||
Adamas Pharmaceuticals, Inc. | COM | 00548A106 | 654 | 172,630 | SH | SOLE | 172,630 | 0 | 0 | ||
Adaptive Biotechnologies Corporation | COM | 00650F109 | 33,373 | 1,115,411 | SH | SOLE | 1,115,411 | 0 | 0 | ||
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 13,092 | 1,713,604 | SH | SOLE | 1,713,604 | 0 | 0 | ||
Affimed N.V. | COM | N01045108 | 548 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Aimmune Therapeutics, Inc. | COM | 00900T107 | 22,556 | 673,908 | SH | SOLE | 673,908 | 0 | 0 | ||
Albireo Pharma, Inc. | COM | 01345P106 | 6,355 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | COM | 015351109 | 893,110 | 8,258,068 | SH | SOLE | 8,258,068 | 0 | 0 | ||
Alkermes plc | SHS | G01767105 | 16,180 | 793,130 | SH | SOLE | 793,130 | 0 | 0 | ||
Allakos Inc. | COM | 01671P100 | 32,393 | 339,690 | SH | SOLE | 339,690 | 0 | 0 | ||
Amarin Corporation plc | SPONSORED ADR | 023111206 | 739,609 | 34,496,685 | SH | SOLE | 34,496,685 | 0 | 0 | ||
AnaptysBio, Inc. | COM | 032724106 | 1,838 | 113,086 | SH | SOLE | 113,086 | 0 | 0 | ||
Apellis Pharmaceuticals, Inc. | COM | 03753U106 | 15,217 | 496,969 | SH | SOLE | 496,969 | 0 | 0 | ||
Aravive, Inc. | COM | 03890D108 | 5,924 | 433,333 | SH | SOLE | 433,333 | 0 | 0 | ||
Arcus Biosciences, Inc. | COM | 03969F109 | 1,227 | 121,534 | SH | SOLE | 121,534 | 0 | 0 | ||
argenx SE | SPONSORED ADR | 04016X101 | 163,659 | 1,019,557 | SH | SOLE | 1,019,557 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 471,654 | 3,390,270 | SH | SOLE | 3,390,270 | 0 | 0 | ||
Assembly Biosciences, Inc. | COM | 045396108 | 31,542 | 1,541,618 | SH | SOLE | 1,541,618 | 0 | 0 | ||
Atreca, Inc. | CL A Common | 04965G109 | 54,652 | 3,532,760 | SH | SOLE | 3,532,760 | 0 | 0 | ||
Audentes Therapeutics, Inc. | COM | 05070R104 | 48,154 | 804,720 | SH | SOLE | 804,720 | 0 | 0 | ||
Aurinia Pharmaceuticals Inc. | COM | 05156V102 | 34,481 | 1,701,929 | SH | SOLE | 1,701,929 | 0 | 0 | ||
Autolus Therapeutics plc | SPONSORED ADS | 05280R100 | 2,069 | 156,773 | SH | SOLE | 156,773 | 0 | 0 | ||
Axsome Therapeutics, Inc. | COM | 05464T104 | 85,764 | 829,757 | SH | SOLE | 829,757 | 0 | 0 | ||
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 1,952,203 | 11,777,285 | SH | SOLE | 11,777,285 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | COM | 079481107 | 3,454 | 2,677,818 | SH | SOLE | 2,677,818 | 0 | 0 | ||
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 37,764 | 10,946,166 | SH | SOLE | 10,946,166 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 641,675 | 7,589,294 | SH | SOLE | 7,589,294 | 0 | 0 | ||
bluebird bio, Inc. | COM | 09609G100 | 3,510 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
Cabaletta Bio, Inc. | COM | 12674W109 | 8,890 | 636,363 | SH | SOLE | 636,363 | 0 | 0 | ||
Catalyst Pharmaceuticals, Inc. | COM | 14888U101 | 5,032 | 1,341,902 | SH | SOLE | 1,341,902 | 0 | 0 | ||
Cerus Corporation | COM | 157085101 | 45,365 | 10,749,937 | SH | SOLE | 10,749,937 | 0 | 0 | ||
ChemoCentryx, Inc. | COM | 16383L106 | 29,228 | 739,016 | SH | SOLE | 739,016 | 0 | 0 | ||
Constellation Pharmaceuticals, Inc. | COM | 210373106 | 6,281 | 133,333 | SH | SOLE | 133,333 | 0 | 0 | ||
Crinetics Pharmaceuticals, Inc. | COM | 22663K107 | 4,391 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
CytomX Therapeutics, Inc. | COM | 23284F105 | 1,615 | 194,377 | SH | SOLE | 194,377 | 0 | 0 | ||
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 156,373 | 14,614,264 | SH | SOLE | 14,614,264 | 0 | 0 | ||
Dynavax Technologies Corporation | COM | 268158201 | 429 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
Evofem Biosciences, Inc. | COM | 30048L104 | 4,670 | 756,813 | SH | SOLE | 756,813 | 0 | 0 | ||
Exact Sciences Corporation | COM | 30063P105 | 239,134 | 2,585,791 | SH | SOLE | 2,585,791 | 0 | 0 | ||
Frequency Therapeutics, Inc. | COM | 35803L108 | 21,587 | 1,231,433 | SH | SOLE | 1,231,433 | 0 | 0 | ||
Fulgent Genetics, Inc. | COM | 359664109 | 7,346 | 569,444 | SH | SOLE | 569,444 | 0 | 0 | ||
G1 Therapeutics, Inc. | COM | 3621LQ109 | 3,363 | 127,236 | SH | SOLE | 127,236 | 0 | 0 | ||
Galapagos NV | SPONSORED ADR | 36315X101 | 2,704 | 13,072 | SH | SOLE | 13,072 | 0 | 0 | ||
Galmed Pharmaceuticals Ltd. | SHS | M47238106 | 1,246 | 215,594 | SH | SOLE | 215,594 | 0 | 0 | ||
GW Pharmaceuticals plc | ADS | 36197T103 | 38,776 | 370,845 | SH | SOLE | 370,845 | 0 | 0 | ||
Harpoon Therapeutics, Inc. | COM | 41358P106 | 3,169 | 214,285 | SH | SOLE | 214,285 | 0 | 0 | ||
Heron Therapeutics, Inc. | COM | 427746102 | 141,425 | 6,018,104 | SH | SOLE | 6,018,104 | 0 | 0 | ||
HOOKIPA Pharma Inc. | COM | 43906K100 | 10,920 | 892,857 | SH | SOLE | 892,857 | 0 | 0 | ||
IDEAYA Biosciences, Inc. | COM | 45166A102 | 1,500 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Idera Pharmaceuticals, Inc. | COM PAR | 45168K405 | 8,388 | 4,608,786 | SH | SOLE | 4,608,786 | 0 | 0 | ||
IGM Biosciences, Inc. | COM | 449585108 | 119,975 | 3,144,000 | SH | SOLE | 3,144,000 | 0 | 0 | ||
Incyte Corporation | COM | 45337C102 | 2,792,221 | 31,976,873 | SH | SOLE | 31,976,873 | 0 | 0 | ||
Infinity Pharmaceuticals, Inc. | COM | 45665G303 | 557 | 580,400 | SH | SOLE | 580,400 | 0 | 0 | ||
Inflarx N.V. | COM | N44821101 | 7,043 | 1,778,415 | SH | SOLE | 1,778,415 | 0 | 0 | ||
Insmed Incorporated | COM PAR $.01 | 457669307 | 58,393 | 2,445,265 | SH | SOLE | 2,445,265 | 0 | 0 | ||
Intellia Therapeutics, Inc. | COM | 45826J105 | 1,886 | 128,538 | SH | SOLE | 128,538 | 0 | 0 | ||
Invitae Corporation | COM | 46185L103 | 146,737 | 9,097,165 | SH | SOLE | 9,097,165 | 0 | 0 | ||
IVERIC bio, Inc. | COM | 46583P102 | 1,216 | 141,750 | SH | SOLE | 141,750 | 0 | 0 | ||
Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | 30,963 | 2,799,577 | SH | SOLE | 2,799,577 | 0 | 0 | ||
Kodiak Sciences Inc. | COM | 50015M109 | 794,852 | 11,047,289 | SH | SOLE | 11,047,289 | 0 | 0 | ||
Krystal Biotech, Inc. | COM | 501147102 | 57,300 | 1,034,674 | SH | SOLE | 1,034,674 | 0 | 0 | ||
Leap Therapeutics, Inc. | COM | 52187K101 | 1,096 | 978,454 | SH | SOLE | 978,454 | 0 | 0 | ||
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 106,533 | 1,169,278 | SH | SOLE | 1,169,278 | 0 | 0 | ||
Marker Therapeutics, Inc. | COM | 57055L107 | 4,320 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
Matinas BioPharma Holdings, Inc. | COM | 576810105 | 5,975 | 2,632,348 | SH | SOLE | 2,632,348 | 0 | 0 | ||
Menlo Therapeutics Inc. | COM | 586858102 | 3,248 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
Merus N.V. | COM | N5749R100 | 28,688 | 2,037,469 | SH | SOLE | 2,037,469 | 0 | 0 | ||
Millendo Therapeutics, Inc. | COM | 60040X103 | 5,617 | 833,333 | SH | SOLE | 833,333 | 0 | 0 | ||
Mirati Therapeutics, Inc. | COM | 60468T105 | 168,448 | 1,307,220 | SH | SOLE | 1,307,220 | 0 | 0 | ||
Mirum Pharmaceuticals, Inc. | COM | 604749101 | 8,173 | 333,333 | SH | SOLE | 333,333 | 0 | 0 | ||
Molecular Templates, Inc. | COM | 608550109 | 4,429 | 316,730 | SH | SOLE | 316,730 | 0 | 0 | ||
MyoKardia, Inc. | COM | 62857M105 | 129,315 | 1,774,234 | SH | SOLE | 1,774,234 | 0 | 0 | ||
Neoleukin Therapeutics, Inc. | COM | 64049K104 | 41,860 | 3,397,740 | SH | SOLE | 3,397,740 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | COM | 64125C109 | 134,819 | 1,254,243 | SH | SOLE | 1,254,243 | 0 | 0 | ||
NextCure, Inc. | COM | 65343E108 | 8,450 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
NGM Biopharmaceuticals, Inc. | COM | 62921N105 | 4,623 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Orchard Therapeutics plc | ADS | 68570P101 | 5,578 | 405,702 | SH | SOLE | 405,702 | 0 | 0 | ||
Principia Biopharma Inc. | COM | 74257L108 | 97,944 | 1,787,957 | SH | SOLE | 1,787,957 | 0 | 0 | ||
Protagonist Therapeutics, Inc. | COM | 74366E102 | 8,279 | 1,174,282 | SH | SOLE | 1,174,282 | 0 | 0 | ||
Ra Pharmaceuticals, Inc. | COM | 74933V108 | 98,264 | 2,093,839 | SH | SOLE | 2,093,839 | 0 | 0 | ||
Reata Pharmaceuticals, Inc. | CL A | 75615P103 | 8,378 | 40,983 | SH | SOLE | 40,983 | 0 | 0 | ||
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 62,180 | 2,708,200 | SH | SOLE | 2,708,200 | 0 | 0 | ||
Sangamo Therapeutics, Inc. | COM | 800677106 | 8,369 | 999,823 | SH | SOLE | 999,823 | 0 | 0 | ||
Seattle Genetics, Inc. | COM | 812578102 | 5,719,544 | 50,057,277 | SH | SOLE | 50,057,277 | 0 | 0 | ||
Spring Bank Pharmaceuticals, Inc. | COM | 849431101 | 969 | 613,144 | SH | SOLE | 613,144 | 0 | 0 | ||
Sunesis Pharmaceuticals, Inc. | COM | 867328700 | 188 | 556,665 | SH | SOLE | 556,665 | 0 | 0 | ||
Syros Pharmaceuticals, Inc. | COM | 87184Q107 | 4,769 | 690,167 | SH | SOLE | 690,167 | 0 | 0 | ||
Tricida, Inc. | COM | 89610F101 | 74,344 | 1,969,905 | SH | SOLE | 1,969,905 | 0 | 0 | ||
Trillium Therapeutics Inc. | COM | 89620X506 | 1,133 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
uniQure N.V. | SHS | N90064101 | 37,098 | 517,700 | SH | SOLE | 517,700 | 0 | 0 | ||
UroGen Pharma Ltd. | COM | M96088105 | 27,747 | 831,488 | SH | SOLE | 831,488 | 0 | 0 | ||
Urovant Sciences Ltd. | SHS | G9381B108 | 15,510 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
Viking Therapeutics, Inc. | COM | 92686J106 | 3,409 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
Xencor, Inc. | COM | 98401F105 | 14,723 | 428,120 | SH | SOLE | 428,120 | 0 | 0 | ||
Y-mAbs Therapeutics, Inc. | COM | 984241109 | 4,329 | 138,514 | SH | SOLE | 138,514 | 0 | 0 | ||
Zymeworks Inc. | COM | 98985W102 | 77,667 | 1,708,472 | SH | SOLE | 1,708,472 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | NOTE 0.599% 8/1/2024 | 09061GAH4 | 15,841 | 15,000,000 | PRN | SOLE | 15,000,000 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | NOTE 2.25% 5/15/2024 | 64125CAD1 | 47,123 | 30,770,000 | PRN | SOLE | 30,770,000 | 0 | 0 |